Natural History of Patients With PH3 and a History of Stone Events
Completed
Conditions studied: Primary Hyperoxaluria Type 3
In brief
This is a natural history study of adults, adolescents, and children (starting at birth) with genetically confirmed primary hyperoxaluria type 3 (PH3) who have a history of stone events during the last 3 years and/or the presence of pre existing stones detected by renal ultrasound at screening.
Key facts
- Study ID
- NCT04542590
- Run by
- Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
- People needed
- 7
- Starts
- 2021-09-09
- Expected to finish
- 2024-07-23
- Last updated by the study team
- 2024-12-02
Who can join
Age: 2 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Clinical Trial Site — Boston, Massachusetts, United States
- Clinical Trial Site — New York, New York, United States
- Clinical Trial Site — Toronto, Ontario, Canada
- Clinical Trial Site — Heidelberg, Germany
- Clinical Trial Site — Warsaw, Poland
- Clinical Trial Site — London, United Kingdom
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.